Not just monitoring; A strategy for managing neuromuscular blockade

Anaesthesia

Volumn 70, Issue 10, 2015, Pages 1105-1109

  Rodney, G ^a   Raju, P K B C ^a   Ball, D R ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b DUMFRIES AND GALLOWAY ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROMUSCULAR BLOCKING AGENT;

GAS EXCHANGE; GENERAL ANESTHESIA; HUMAN; INTRAOPERATIVE AWARENESS; NERVE STIMULATION; NEUROMUSCULAR BLOCKING; NONHUMAN; PATIENT HARM; PATIENT MONITORING; PERIPHERAL NERVE STIMULATOR; PRACTICE GUIDELINE; QUALITATIVE ANALYSIS; REVIEW; WAKEFULNESS; ANTAGONISTS AND INHIBITORS; PERIOPERATIVE PERIOD; PHYSIOLOGIC MONITORING; PROCEDURES; TRENDS;

HUMANS; MONITORING, PHYSIOLOGIC; NEUROMUSCULAR BLOCKADE; NEUROMUSCULAR BLOCKING AGENTS; PERIOPERATIVE CARE;

EID: 84941686429     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/anae.13219     Document Type: Review

References (47)

1. th National Audit Project (NAP5) on accidental awareness during general anaesthesia: summary of main findings and risk factors. Anaesthesia 2014; 69: 1089-101.
2. Eriksson LL,. Evidence based practice and neuromuscular monitoring. Its time for routine quantitative assessment. Anesthesiology 2003; 98: 1037-9.
3. Brull SJ, Prielipp RC,. Reversal of neuromuscular blockade: 'identification friend or foe'. Anesthesiology 2015; 122: 1183-5.
4. Berg H, Roed J, Viby-Mogensen J, et al., Residual neuromuscular block is a risk factor for postoperative pulmonary complications. A prospective, randomised, and blinded study of postoperative pulmonary complications after atracurium, vecuronium and pancuronium. Acta Anaesthesiologica Scandinavica 1997; 41: 1095-103.
5. Debaene B, Plaud B, Dilly MP, Donati F,. Residual paralysis in the PACU after a single intubating dose of non-depolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-8.
6. Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ,. A survey of current management of neuromuscular block in the United States and Europe. Anesthesia and Analgesia 2010; 111: 110-19.
7. Caldwell JE,. Reversal of residual neuromuscular blockade with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesthesia and Analgesia 1995; 80: 1168-74.
8. Grosse-Sundrup M, Henenman JP, Sandberg WS, et al., Intermediate acting non depolarizing neuromuscular blocking agents and risk of postoperative respiratory complications: prospective propensity score matched cohort study. British Medical Journal 2012; 345: e6329.
9. Herbstreit F, Zigrahn D, Ochterbeck C, Peters J, Eikermann M,. Neostigmine / glycopyrrolate administered after recovery from neuromuscular block increases upper airway collapsibility by decreasing genioglossus muscle activity in response to negative pharyngeal pressure. Anesthesiology 2010; 113: 1280-8.
10. Eikermann M, Fassbender P, Malhotra A, et al., Unwarranted administration of acetylcholinesterase inhibitors can impair genioglossus and diaphragm function. Anesthesiology 2007; 107: 621-9.
11. Mclean DJ, Diaz-Gil D, Farhan HN, Ladha KS, Kurth T, Eikermann M,. Dose-dependant association between intermediate-acting neuromuscular-blocking agents and postoperative respiratory complications. Anesthesiology 2015; 122: 1201-13.
12. Illman HL, Laurila P, Antila H, Meretoha OA, Alahunta S, Olkkola KT,. The duration of neuromuscular block after administration of neostigmine or sugammadex at two visible twitches during train-of-four monitoring. Anesthesia and Analgesia 2011; 112: 63-68.
13. Kim KS, Cheong MA, Lee HJ, Lee JM,. Tactile assessment for the reversibility of rocuronium induced neuromuscular blockade during propofol or sevoflurane anaesthesia. Anesthesia and Analgesia 2004; 99: 1080-5.
14. Kopman AF, Zank LM, Ng J, Neuman GG,. Antagonism of cisatracurium and rocuronium block at train of four count 2: should quantitative assessment of neuromuscular function be mandatory? Anesthesia and Analgesia 2004; 98: 102-6.
15. Srivastava A, Hunter JM,. Reversal of neuromuscular block. British Journal of Anaesthesia 2009; 103: 115-29.
16. Kotake Y, Ochiai R, Suzuki T, et al., Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block. Anesthesia and Analgesia 2013; 117: 345-51.
17. Naguib M, Brull SJ, Harkes HR,. Reasoning of an anomaly: residual block after sugammadex. Anesthesia and Analgesia 2013; 117: 297-300.
18. Tsur A, Kalansky A,. Hypersensitivity associated with sugammadex administration: a systematic review. Anaesthesia 2014; 69: 1251-7.
19. Paton F, Paulden M, Chambers D, et al., Sugammadex compared with neostigmine / glycopyrrolate for routine reversal of neuromuscular block: a systematic review and economic evaluation. British Journal of Anaesthesia 2010; 105: 558-67.
20. Murphy GS, Brull SJ,. Residual neuromuscular block: lessons unlearned. Part II: methods to reduce the risk of residual weakness. Anesthesia and Analgesia 2010; 111: 129-40.
21. Donati F,. Neuromuscular Blockers and their Reversal in 2010. http://www.iars.org/assets/1/7/IARS-RCL10-02.pdf (accessed 15/07/2015).
22. Kopman AF, Eikermann M,. Antagonism of non-depolarising neuromuscular block: current practice. Anaesthesia 2009; 64 (Suppl. 1): 22-30.
23. Viby-Mogenson J, Jenson NH, Engbaek J, Ording H, Skovgaard LT, Chaemmmer-Jorgensen B,. Tactile and visual evaluation of the response to train of four nerve stimulation. Anesthesiology 1985; 63: 440-3.
24. Capron F, Fortier L-P, Racine S, et al., Tactile fade detection with hand or wrist stimulation using train of four, double burst stimulus, 50-hertz tetanus, 100-Hertz tetanus and acceleromyography. Anesthesia and Analgesia 2006; 102: 1578-84.
25. Murphy GS, Szokol JW, Marymont JH, et al., Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the post anaesthesia care unit. Anesthesiology 2008; 109: 389-98.
26. Murphy GS, Szokol JW, Avram MJ, et al., Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology 2011; 115: 946-54.
27. Murphy GS, Brull SJ,. Residual neuromuscular block: lessons unlearned. Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. Anesthesia and Analgesia 2010; 111: 120-8.
28. Ali HH, Wilson RS, Savarese JJ, Kitz RJ,. The effect of tubocurarine on indirectly elicited train of four muscle response and respiratory measurements in humans. British Journal of Anaesthesia 1975; 47: 570-74.
29. Viby-Mogensen J, Jorgensen BC, Ording H,. Residual curarization in the recovery room. Anesthesiology 1979; 50: 539-41.
30. Bevan DR, Smith CE, Donati F,. Postoperative neuromuscular blockade: a comparison between atracurium, vecuronium and pancuronium. Anesthesiology 1988; 69: 272-6.
31. Naguib M, Kopman AF, Ensor JE,. Neuromuscular monitoring and postoperative residual curarisation: a meta-analysis. British Journal of Anaesthesia 2007; 98: 302-16.
32. Baillard C, Gehan G, Rebou-Marty J, et al., Residual curarisation in the recovery room after vecuronium. British Journal of Anaesthesia 2000; 84: 394-5.
33. Hayes AH, Mirakhur RK, Breslin DS, Reid JE, McCourt KC,. Postoperative residual block after intermediate-acting neuromuscular blocking drugs. Anaesthesia 2001; 56: 312-8.
34. Grayling MI, Sweeney BP,. Recovery from neuromuscular blockade: a survey of practice. Anaesthesia. 2007; 62: 806-9.
35. Di Marco P, Della Rocca G, Iannuccelli F, Pompei L, Reale C, Pietropaoli P,. Knowledge of residual curarization: an Italian Survey. Acta Anaesthesiologica Scandinavica 2010; 54: 307-12.
36. Sundman E, Witt H, Olsson R, Ekberg O, Kuylenstierna R, Eriksson LI,. The incidence and mechanisms of pharyngeal and upper oesophogeal dysfunction in partially paralysed humans: pharyngeal videoradiography and simultaneous manometry after atracurium. Anesthesiology 2000; 92: 977-84.
37. Eikermann M, Groeben H, Husing J, Peters J,. Accelerometry of adductor pollicis muscle predicts recovery of respiratory function from neuromuscular blockade. Anesthesiology 2003; 98: 1333-7.
38. Eriksson LI, Sundman E, Olsson R, et al., Functional assessment of the pharynx at rest and swallowing in partially paralysed humans: simultaneous videomanometry and mechanomyography of awake human volunteers. Anesthesiology 1997; 86: 1035-43.
39. Beecher HK, Todd DP,. A study of the deaths associated with anaesthesia and surgery. Annals of Surgery 1954; 140: 2-35.
40. Arbous MS,. Mortality associated with anaesthesia: a qualitative analysis to identify risk factors. Anaesthesia 2001; 56: 1141-53.
41. Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS,. Residual neuromuscular blockade and critical respiratory events in the post anaesthesia care unit. Anesthesianda Analgesia 2008; 107: 130-7.
42. Baillard C, Clec'h C, Catineau J, et al., Postoperative residual neuromuscular block: a survey of management. British Journal of Anaesthesia 2005; 95: 622-6.
43. Todd MM, Hindman BJ, King BJ,. The implementation of quantitative electromyographic neuromuscular monitoring in an academic anaesthesia department. Anesthesia and Analgesia 2014; 119: 323-31.
44. Combes X, Andriamifidy L, Dufresne E, et al., Comparison of two induction regimes using or not using muscle relaxant: impact on postoperative upper airway discomfort. British Journal of Anaesthesia 2007; 99: 276-81.
45. Mencke T, Echternach M, Kleinschmidt S, et al., Laryngeal morbidity and quality of tracheal intubation: a randomized controlled trial. Anesthesiology 2003; 98: 1049-56.
46. Patel A,. Facemask ventilation before or after neuromuscular blocking drugs: where are we now? Anaesthesia 2014; 69: 811-5.
47. Cook TM, Woodall N, Frerk C,. Major complications of airway management in the UK: results of the Fourth National Audit Project of the Royal College of Anaesthetists and the Difficult Airway Society. Part 1: Anaesthesia. British Journal of Anaesthesia 2011; 106: 617-31.